Skip to main content

Table 3 Distribution and characteristics of first-line antiretroviral experienced adults with HIV-1 acquired drug resistance mutations from a rural HIV clinic in coastal Kenya

From: HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study

No.

Gender

Age (years)

Sample date

ART date

ART duration#

Viral load

Subtype*

NRTI mutations

NNRTI mutations

1.

Male

30.5

28-Nov-08

28-Mar-08

8.0

697796

Complex

D67DG

K103N, G190A

2.

Female

38.5

02-Dec-08

22-May-08

6.4

5006

A1

M184V

K103N, K238T

3.

Male

36.6

06-Jan-09

11-Apr-08

8.9

861730

A1

M184V

Y188L

4.

Female

33.4

17-Nov-08

19-May-08

6.0

64435

A1

M184V, K219EK

V108IV, Y181CY, G190AG

5.

Female

44.5

16-Dec-08

26-Nov-07

12.7

3087

A1

M184V

G190A

6.

Female

26.5

17-Dec-08

01-Nov-07

13.5

1158

D

M184V

K103N, K238T

7.

Female

22.5

05-Dec-08

30-Oct-07

13.2

4051

A1

M184V

K103N

8.

Female

48.4

12-Nov-08

02-Jul-07

16.4

5274

A1

M184V

K103N, M230LM

9.

Female

24.4

12-Nov-08

29-Aug-07

14.5

24529

D

T69NT, M184V

K103N

10.

Female

63.4

21-Nov-08

03-May-07

18.7

576

A1, AE

 

K103N

11.

Female

25.6

14-Jan-09

22-Oct-07

14.8

219766

A-ancestral, A1

M184V, T215Y

Y181C

12.

Female

31.3

07-Oct-10

22-Aug-08

25.5

315800

A1

M184V

K103N

13.

Female

34.0

22-Jun-10

07-Oct-09

8.5

17248

A1

M184V

Y181C

14.

Female

25.2

13-Sep-10

19-Aug-09

12.8

109090

D

M184V

V106A, F227L

15.

Female

51.2

10-Aug-10

15-Jun-09

13.8

5396

A1

M184V

K103N

16.

Female

23.7

08-Mar-11

22-Sep-09

17.5

12408

A1

M184V

Y181C

17.

Female

32.1

06-Jul-10

15-Dec-08

18.7

199362

A1

M41L, D67N, K70R, M184V, T215Y, K219Q

Y181IV

18.

Female

31.8

23-Mar-11

27-Feb-09

24.8

834656

A-ancestral, A1

 

K101E, G190A

19.

Female

38.7

16-Feb-10

22-May-09

8.9

34186

A2

M184V

V106A

20.

Female

41.8

20-Apr-10

22-Jun-09

9.9

4729

A1

M184V

Y181C

21.

Female

31.7

04-Mar-11

24-Mar-09

23.3

20392

A1

M184V

V106A

22.

Female

15.1

16-Mar-10

13-Apr-09

11.1

1046760

A1

M184V

K103S, G190A

23.

Female

31.3

29-Sep-10

11-Jan-10

8.6

129493

A1, A2

 

K103N

24.

Female

41.7

11-Mar-11

18-Aug-09

18.7

1452

A, A1

M184V

Y181C

25.

Female

17.8

07-Mar-11

08-Dec-09

14.9

130222

A1

M184V

K103N, Y318FY

26.

Female

25.7

04-Mar-11

13-Apr-10

10.7

47795

A1

M184V

K101Q, G190A

27.

Female

21.7

11-Mar-11

01-Sep-09

18.3

2029880

A1

L74V, M184V

K103N, Y181C

28.

Female

48.1

02-Aug-10

08-Oct-08

21.8

72430

A1

 

G190A

29.

Male

29.5

14-Dec-10

06-Jan-10

11.2

74152

A, A1

K65R, M184V

K103N

  1. #Time (in months) since patient started taking antiretroviral therapy, *HIV-1 subtypes identified using the ‘Subtype Classification Using Evolutionary ALgorithm (SCUEAL)’ tool, available at (http://www.datamonkey.org/dataupload_scueal.php).